Your search history is turned on.
Date: April 15, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
NuGen Announces Debt Settlement and Amendments to Care4Pharma Share Purchase Agreement April 15th, 2024 Toronto, Ontario NuGen Medical Devices Inc. (TSXV: NGMD) (the Company or "NuGen") announces that it has agreed to settle an aggregate of 275,000 of indebtedness owed to Care4Pharma B.V. (Care4Pharma), an arm...
Date: January 30, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
NuGen Announces Completion of Product Training with Sol Millennium as European Markets Expand January 30th, 2023 Toronto, Ontario NuGen Medical Devices Inc. (TSXV: NGMD) (the Company or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that as o...
Date: January 19, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
NuGen Receives Two Additional Sales Orders for InsuJet and Expands Distribution into Argentina, Chile, Costa Rica and Peru January 19th, 2024 Toronto, Ontario NuGen Medical Devices Inc. (TSXV: NGMD) (the Company or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to report th...
Date: December 19, 2023 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
NuGen Medical Signs 5-year Distribution Agreement for InsuJet with Verrue Consulting Group in Belgium December 19th, 2023 Toronto, Ontario NuGen Medical Devices Inc. (TSXV: NGMD) (the Company or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to a...
Date: December 14, 2023 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
NuGen Medical Signs 5-year Distribution Agreement for InsuJet with Advance Medical Life Co. December 14th, 2023 Toronto, Ontario NuGen Medical Devices Inc. (TSXV: NGMD) (the Company or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce th...
Date: November 29, 2023 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
Microsoft Word - NuGen - MDA - Q3 2023_Final Page 1 of 17 Managements Discussion and Analysis For the three and nine-month periods ended September 30, 2023 and 2022 Page 2 of 17 This Managements Discussion and Analysis (MD&A) of financial results is dated Nov...
Microsoft Word - Form 52-109FV2 - CFO - Q3 2023 FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Veronique Laberge, Chief Financial Officer of NuGen Medical Devices Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of NuGen Medical D...
Microsoft Word - Form 52-109FV2 - CEO - Q3 2023 FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Ian Heynen, Chief Executive Officer of NuGen Medical Devices Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of NuGen Medical Devices I...
Microsoft Word - NuGen FS Q3 2023 - Final NuGen Medical Devices Inc. Interim Condensed Consolidated Financial Statements For the three and nine-month periods ended September 30, 2023 and 2022 (Unaudited) MANAGEM...
Date: November 13, 2023 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
InsuJet Registered as a Medical Device in Mexico Second Bulk Sale for InsuJet Now Paid in Full November 13th, 2023 Toronto, Ontario NuGen Medical Devices Inc. (TSXV: NGMD) (the Company or "NuGen") is pleased to announce the Mexican government has completed the registration of NuGens needle-free InsuJet injection devic...